Regulation - Pricing, Financial

Filter

Current filters:

PricingFinancial

Popular Filters

Briefs: Elan tender offer; German drug price review; Daiichi Sankyo pays milestone

19-04-2013

Ireland-based drugmaker Elan (NYSE: ELN) yesterday reported final results of its modified Dutch auction…

ActemraAmgenAnticalinBayerElanFinancialNovo NordiskPharmaceuticalPradaxaPricingProliaRegulationResearchRocheVictozaXarelto

The solution for Spanish pharma companies lies abroad

13-03-2013

The pressure on the prices of medicines by Spanish government has seen the pharmaceutical market in Spain…

AlmirallEuropeFinancialGrifolsPharmaceuticalPricingRegulationZeltia

A blip or stark reality? Pharma companies re-evaluate emerging markets

28-08-2012

Pharmaceutical companies, which have previously been allaying the growing fears and concerns of their…

FinancialGlobalMarkets & MarketingPharmaceuticalPricingRegulation

Venezuelan govt increasing control over pharmaceutical sector

14-08-2012

Venezuela's national government has changed its policy with regard to the pharmaceutical sector. This…

FinancialGenericsPharmaceuticalPricingRegulationSouth America

Where to now for UK Life Sciences?

16-12-2011

The 2012 UK Life Science Industry Leaders Survey* highlights a concern that the UK is losing its position…

BiotechnologyEuropeFinancialPharmaceuticalPricingRegulationResearch

Investment in medicines highest in PHARMAC history

15-12-2011

A surge in the medicines budget over the past three years, combined with New Zealand’s health regulatory…

Asia-PacificBiotechnologyFinancialPharmaceuticalPricingRegulation

Back to top